QQQ   317.81 (-0.19%)
AAPL   125.47 (+0.28%)
MSFT   232.20 (-0.71%)
FB   259.98 (+0.38%)
GOOGL   2,073.81 (+0.45%)
TSLA   690.25 (+0.56%)
AMZN   3,097.01 (+0.08%)
NVDA   536.19 (-0.01%)
BABA   237.97 (+1.51%)
CGC   35.16 (-0.26%)
GE   13.11 (+1.00%)
MU   90.79 (-0.33%)
NIO   44.34 (+2.43%)
AMD   83.97 (-0.19%)
T   28.25 (+0.11%)
F   12.51 (-0.32%)
ACB   11.19 (+1.45%)
DIS   195.99 (+1.06%)
BA   227.28 (+1.86%)
NFLX   546.95 (-0.16%)
PFE   33.56 (+0.15%)
QQQ   317.81 (-0.19%)
AAPL   125.47 (+0.28%)
MSFT   232.20 (-0.71%)
FB   259.98 (+0.38%)
GOOGL   2,073.81 (+0.45%)
TSLA   690.25 (+0.56%)
AMZN   3,097.01 (+0.08%)
NVDA   536.19 (-0.01%)
BABA   237.97 (+1.51%)
CGC   35.16 (-0.26%)
GE   13.11 (+1.00%)
MU   90.79 (-0.33%)
NIO   44.34 (+2.43%)
AMD   83.97 (-0.19%)
T   28.25 (+0.11%)
F   12.51 (-0.32%)
ACB   11.19 (+1.45%)
DIS   195.99 (+1.06%)
BA   227.28 (+1.86%)
NFLX   546.95 (-0.16%)
PFE   33.56 (+0.15%)
QQQ   317.81 (-0.19%)
AAPL   125.47 (+0.28%)
MSFT   232.20 (-0.71%)
FB   259.98 (+0.38%)
GOOGL   2,073.81 (+0.45%)
TSLA   690.25 (+0.56%)
AMZN   3,097.01 (+0.08%)
NVDA   536.19 (-0.01%)
BABA   237.97 (+1.51%)
CGC   35.16 (-0.26%)
GE   13.11 (+1.00%)
MU   90.79 (-0.33%)
NIO   44.34 (+2.43%)
AMD   83.97 (-0.19%)
T   28.25 (+0.11%)
F   12.51 (-0.32%)
ACB   11.19 (+1.45%)
DIS   195.99 (+1.06%)
BA   227.28 (+1.86%)
NFLX   546.95 (-0.16%)
PFE   33.56 (+0.15%)
QQQ   317.81 (-0.19%)
AAPL   125.47 (+0.28%)
MSFT   232.20 (-0.71%)
FB   259.98 (+0.38%)
GOOGL   2,073.81 (+0.45%)
TSLA   690.25 (+0.56%)
AMZN   3,097.01 (+0.08%)
NVDA   536.19 (-0.01%)
BABA   237.97 (+1.51%)
CGC   35.16 (-0.26%)
GE   13.11 (+1.00%)
MU   90.79 (-0.33%)
NIO   44.34 (+2.43%)
AMD   83.97 (-0.19%)
T   28.25 (+0.11%)
F   12.51 (-0.32%)
ACB   11.19 (+1.45%)
DIS   195.99 (+1.06%)
BA   227.28 (+1.86%)
NFLX   546.95 (-0.16%)
PFE   33.56 (+0.15%)
Log in
NYSE:LH

Laboratory Co. of America Stock Forecast, Price & News

$243.60
+2.10 (+0.87 %)
(As of 03/3/2021 09:32 AM ET)
Add
Compare
Today's Range
$242.50
Now: $243.60
$243.60
50-Day Range
$214.81
MA: $231.56
$247.15
52-Week Range
$98.02
Now: $243.60
$252.45
Volume131 shs
Average Volume802,608 shs
Market Capitalization$23.73 billion
P/E Ratio28.36
Dividend YieldN/A
Beta1.09
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular and infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other procedures. In addition, it provides a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, QIAGEN N.V, Ciox Health, Circuit Clinical, and Riverside Medical Group. The company was founded in 1971 and is headquartered in Burlington, North Carolina.
Laboratory Co. of America logo

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127
Employees75,000
Year Founded1976

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.55 billion
Cash Flow$21.52 per share
Book Value$77.93 per share

Profitability

Net Income$823.80 million

Miscellaneous

Market Cap$23.73 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.56 out of 5 stars

Medical Sector

373rd out of 1,969 stocks

Medical Laboratories Industry

4th out of 39 stocks

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$243.60
+2.10 (+0.87 %)
(As of 03/3/2021 09:32 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Laboratory Co. of America (NYSE:LH) Frequently Asked Questions

Is Laboratory Co. of America a buy right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Laboratory Co. of America in the last twelve months. There are currently 1 hold rating and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Laboratory Co. of America stock.
View analyst ratings for Laboratory Co. of America
or view top-rated stocks.

What stocks does MarketBeat like better than Laboratory Co. of America?

Wall Street analysts have given Laboratory Co. of America a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Laboratory Co. of America wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Laboratory Co. of America?

Laboratory Co. of America saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 1,360,000 shares, a decrease of 15.5% from the December 31st total of 1,610,000 shares. Based on an average trading volume of 683,700 shares, the days-to-cover ratio is currently 2.0 days. Approximately 1.4% of the shares of the company are short sold.
View Laboratory Co. of America's Short Interest
.

When is Laboratory Co. of America's next earnings date?

Laboratory Co. of America is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Laboratory Co. of America
.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) announced its quarterly earnings results on Wednesday, February, 10th. The medical research company reported $10.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $8.11 by $2.45. Laboratory Co. of America had a net margin of 6.79% and a trailing twelve-month return on equity of 21.05%.
View Laboratory Co. of America's earnings history
.

How has Laboratory Co. of America's stock been impacted by COVID-19 (Coronavirus)?

Laboratory Co. of America's stock was trading at $158.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LH stock has increased by 53.2% and is now trading at $243.65.
View which stocks have been most impacted by COVID-19
.

What guidance has Laboratory Co. of America issued on next quarter's earnings?

Laboratory Co. of America updated its FY 2021 Pre-Market earnings guidance on Thursday, February, 11th. The company provided earnings per share (EPS) guidance of 19.00-23.00 for the period, compared to the Thomson Reuters consensus estimate of $20.14. The company issued revenue guidance of $13.84-14.609 billion, compared to the consensus revenue estimate of $14.15 billion.

What price target have analysts set for LH?

15 Wall Street analysts have issued 1 year price objectives for Laboratory Co. of America's shares. Their forecasts range from $170.00 to $279.00. On average, they expect Laboratory Co. of America's stock price to reach $235.47 in the next twelve months. This suggests that the stock has a possible downside of 3.4%.
View analysts' price targets for Laboratory Co. of America
or view top-rated stocks among Wall Street analysts.

Who are Laboratory Co. of America's key executives?

Laboratory Co. of America's management team includes the following people:
  • Mr. Adam H. Schechter, Pres, CEO & Chairman (Age 56, Pay $1.79M) (LinkedIn Profile)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 60, Pay $1.46M) (LinkedIn Profile)
  • Mr. Lance V. Berberian, Exec. VP and Chief Information & Technology Officer (Age 58, Pay $876.62k) (LinkedIn Profile)
  • Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH, Exec. VP, Pres of Diagnostics & Chief Medical Officer (Age 47, Pay $3.36M)
  • Mr. Mark S. Schroeder, Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain (Age 60, Pay $3.19M)
  • Dr. Michelle Abelson, Laboratory Director of Operations
  • Mr. Peter J. Wilkinson, Sr. VP & Chief Accounting Officer (Age 50) (LinkedIn Profile)
  • Dr. Marcia T. Eisenberg, Chief Scientific Officer & Sr. VP (LinkedIn Profile)
  • Clarissa Willett, VP of Investor Relations
  • Ms. Sandra D. Van Der Vaart, Exec. VP, Chief Legal Officer, Chief Compliance Officer & Corp. Sec. (Age 61)

What is Adam Schechter's approval rating as Laboratory Co. of America's CEO?

143 employees have rated Laboratory Co. of America CEO Adam Schechter on Glassdoor.com. Adam Schechter has an approval rating of 73% among Laboratory Co. of America's employees.

Who are some of Laboratory Co. of America's key competitors?

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Co. of America investors own include Gilead Sciences (GILD), Micron Technology (MU), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), NVIDIA (NVDA), Abbott Laboratories (abt), AbbVie (ABBV), Alibaba Group (BABA) and Amgen (AMGN).

What is Laboratory Co. of America's stock symbol?

Laboratory Co. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Who are Laboratory Co. of America's major shareholders?

Laboratory Co. of America's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.04%), Nordea Investment Management AB (1.95%), Lazard Asset Management LLC (1.46%), JPMorgan Chase & Co. (1.46%), Dimensional Fund Advisors LP (1.44%) and Morgan Stanley (1.25%). Company insiders that own Laboratory Co. of America stock include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Jean-Luc Belingard, Judith C Seltz, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, R Sanders Williams and Robert E Mittelstaedt Jr.
View institutional ownership trends for Laboratory Co. of America
.

Which institutional investors are selling Laboratory Co. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Teacher Retirement System of Texas, Viking Global Investors LP, New York State Common Retirement Fund, Schroder Investment Management Group, AJO LP, CI Investments Inc., and Janus Henderson Group PLC. Company insiders that have sold Laboratory Co. of America company stock in the last year include Der Vaart Sandra D Van, Mark S Schroeder, Paul R Kirchgraber, Peter J Wilkinson, and R Sanders Williams.
View insider buying and selling activity for Laboratory Co. of America
or view top insider-selling stocks.

Which institutional investors are buying Laboratory Co. of America stock?

LH stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Veritas Investment Partners UK Ltd., Assenagon Asset Management S.A., Morgan Stanley, Renaissance Technologies LLC, State of Michigan Retirement System, Nordea Investment Management AB, and Thompson Siegel & Walmsley LLC.
View insider buying and selling activity for Laboratory Co. of America
or or view top insider-buying stocks.

How do I buy shares of Laboratory Co. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Laboratory Co. of America's stock price today?

One share of LH stock can currently be purchased for approximately $243.65.

How much money does Laboratory Co. of America make?

Laboratory Co. of America has a market capitalization of $23.73 billion and generates $11.55 billion in revenue each year. The medical research company earns $823.80 million in net income (profit) each year or $11.32 on an earnings per share basis.

How many employees does Laboratory Co. of America have?

Laboratory Co. of America employs 75,000 workers across the globe.

When was Laboratory Co. of America founded?

Laboratory Co. of America was founded in 1976.

What is Laboratory Co. of America's official website?

The official website for Laboratory Co. of America is www.labcorp.com.

Where are Laboratory Co. of America's headquarters?

Laboratory Co. of America is headquartered at 358 South Main Street, BURLINGTON NC, 27215.

How can I contact Laboratory Co. of America?

Laboratory Co. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.